Man Group plc bought a new position in Centene Corporation (NYSE:CNC - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 2,795,138 shares of the company's stock, valued at approximately $179,420,000. Man Group plc owned about 0.57% of Centene at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in the company. MidFirst Bank bought a new position in shares of Centene during the second quarter valued at approximately $32,000. Fiduciary Financial Advisors bought a new stake in shares of Centene during the 2nd quarter worth approximately $34,000. DV Equities LLC purchased a new position in Centene during the 4th quarter valued at $26,000. Elevation Wealth Partners LLC grew its position in Centene by 564.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 658 shares of the company's stock valued at $42,000 after acquiring an additional 559 shares during the last quarter. Finally, IFC & Insurance Marketing Inc. purchased a new stake in Centene in the fourth quarter worth $28,000. 93.63% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the stock. Stifel Nicolaus set a $79.00 target price on shares of Centene in a research note on Monday, August 3rd. Jefferies Financial Group raised their price target on shares of Centene from $39.00 to $48.00 and gave the stock a "hold" rating in a research note on Wednesday, April 29th. Deutsche Bank Aktiengesellschaft upgraded shares of Centene from a "hold" rating to a "buy" rating and lifted their price objective for the company from $53.00 to $80.00 in a report on Wednesday, May 20th. UBS Group set a $79.00 target price on shares of Centene in a research note on Tuesday, August 18th. Finally, Barclays reaffirmed an "overweight" rating and set a $80.00 price target (up from $75.00) on shares of Centene in a research note on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $70.05.
Get Our Latest Analysis on CNC
Insider Buying and Selling at Centene
In other news, General Counsel Christopher Koster sold 47,603 shares of Centene stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $65.36, for a total value of $3,111,332.08. Following the transaction, the general counsel owned 305,354 shares of the company's stock, valued at $19,957,937.44. The trade was a 13.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.37% of the company's stock.
Centene Trading Down 1.1%
CNC opened at $64.92 on Wednesday. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.71. The firm has a market cap of $32.07 billion, a price-to-earnings ratio of -6.22, a PEG ratio of 0.35 and a beta of 1.08. Centene Corporation has a 12 month low of $28.24 and a 12 month high of $69.36. The stock has a fifty day moving average price of $65.08 and a 200-day moving average price of $52.80.
Centene (NYSE:CNC - Get Free Report) last issued its quarterly earnings data on Monday, July 27th. The company reported $2.51 earnings per share for the quarter, beating analysts' consensus estimates of $1.09 by $1.42. The company had revenue of $53.58 billion for the quarter, compared to the consensus estimate of $47.64 billion. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The firm's revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter last year, the company earned ($0.16) earnings per share. As a group, equities research analysts anticipate that Centene Corporation will post 4.89 earnings per share for the current fiscal year.
About Centene
(
Free Report)
Centene Corporation NYSE: CNC is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children's Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene's offerings extend beyond traditional insurance to include a range of specialty and support services.
Further Reading
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.